A BLa80 Probiotic Trial and Baby Eczema: Why One Large Difference Needs Context

Dr. Arsy Editorial Team · November 9, 2026

A 2026 trial reported a large difference in eczema incidence, but it studied a specific high-risk group and strain. Researchers randomized 360 formula-fed infants and children under age three to Bifidobacterium lactis BLa80 or placebo for 180 days. The result is not a guarantee that any probiotic will prevent eczema. ^[13]

Who was included?

The study enrolled young children with elevated allergy risk, and 337 of the 360 randomized participants were included in the final analysis: 170 in the probiotic group and 167 in the placebo group. The preparation, dose, formula-feeding population and six-month period matter when interpreting the findings. A selected trial population is not a representative sample of all babies. ^[13]

What did the authors report?

Reported eczema incidence was 27.6% in the probiotic group and 69.5% in the placebo group over the study period. These are group percentages from that study, not an individual prediction and not a result that can be assigned to a different strain or brand. The unusually high reported incidence in the comparison group and the study's particular eligibility criteria make independent replication and careful definition of eczema especially important before generalizing. ^[13]

The authors also reported differences in respiratory outcomes, gut measurements and immune markers. Multiple outcomes do not all establish the same result, and microbiome changes do not prove which pathway caused a clinical difference. A short trial also cannot establish all long-term effects. ^[13]

Why compare it with broader reviews?

A separate 2026 infant-only prevention review, which searched through January 8, 2026, found no statistically significant overall preventive effect across the earlier studies it included. The BLa80 paper appeared later and was not part of that original search window. The 2026 AAD pediatric prevention guideline conditionally recommends against probiotic supplementation for primary eczema prevention. These sources show why one positive trial should be considered alongside the wider, changing evidence. ^[1][13][19]

Other prevention studies used different single strains, mixtures and timing, sometimes including maternal supplementation. Treatment trials in children who already had eczema answer another question again. ^{[2][3][8][12][14][16][17][18]}

What should parents do?

Do not start a baby on a probiotic solely because of a headline. Discuss age, medical history, feeding and the precise product with the pediatrician, particularly for premature or medically fragile infants. A supplement does not replace diagnosis, regular care or prescribed treatment for a child who already has eczema. ^[19][20]

Research beyond a single study

The references below include trials in different age groups, reviews of treatment and prevention, and clinical guidelines. A study of one bacterial strain, combination or age group cannot be assigned automatically to another. Clinical outcomes should be considered separately from laboratory markers, and pooled reviews may include some of the same individual studies. ^{[1][5][6][19][20]}

Care for dry, sensitive skin

Explore Dr. Arsy™ Hydration Recovery Moisturizer #003, 4 oz, a fragrance-free moisturizer for dry, sensitive and eczema-prone skin. These probiotic studies did not test #003 and do not show that it prevents or treats eczema. Ask a clinician before choosing a product for a baby.

Related reading

• Can Probiotics Prevent Baby Eczema? What 18 Trials Found
• LGG for Young Children With Eczema: Why Two Trials Reached Different Results
• Probiotics for Children's Eczema: What a 70-Participant Trial Actually Measured
• Probiotics and Adult Eczema: Reading a Seven-Trial Review Without Overpromising
• Baby eczema prevention: comparing major moisturizer studies
• A skin-bacteria safety trial: what its outcome means

Research and clinical references

1. Infant-only probiotics and eczema prevention: 18-trial meta-analysis.
2. ProPAD: Lactobacillus rhamnosus GG in young children.
3. Earlier placebo-controlled infant trial of LGG.
4. Probiotic mixture in children and adolescents: randomized trial.
5. Probiotics for adult eczema: systematic review.
6. Pediatric probiotic treatment: 13-trial systematic review.
7. Pediatric probiotic treatment: meta-analysis.
8. Probiotic mixture in children and adolescents: six-month trial.
9. Multistrain probiotic in adults: placebo-controlled trial.
10. Probiotic supplement in adults: randomized controlled trial.
11. Probiotic supplement in preschool children: randomized trial.
12. Probiotics started in later infancy: prevention trial.
13. B. lactis BLa80 in high-risk young children: prevention trial.
14. Probiotic studies in children: umbrella review.
15. Comparative probiotic strains for pediatric eczema treatment.
16. Comparative probiotic strains for pediatric eczema prevention.
17. Probiotics for prevention in children: systematic review.
18. Prenatal and postnatal probiotic timing: systematic review.
19. AAD guideline: pediatric eczema primary prevention.
20. AAD guideline: pediatric eczema management.
21. AAD guideline: adult eczema topical management.

Educational information; not individual medical advice. Cited researchers and organizations do not endorse Dr. Arsy products.